Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hussein A Tawbi

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Cancer Journal (Sudbury, Mass.)|March 25, 2024
Local and Systemic Management Options for Melanoma Brain MetastasesAfsaneh Amouzegar, Hussein A Tawbi
Neuro-Oncology Advances|December 3, 2021
Emergent immunotherapy approaches for brain metastasesJianbo Wang, Hussein A Tawbi
Expert Opinion on Investigational Drugs|April 17, 2012
A potential role for nilotinib in KIT-mutated melanomaAn Tran, Hussein A Tawbi
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2021
Nonsurgical Management of Melanoma Brain Metastasis: Current Therapeutics, Challenges, and Strategies for ProgressShalini Makawita, Hussein A Tawbi
Therapeutic Advances in Medical Oncology|July 24, 2023
The introduction of LAG-3 checkpoint blockade in melanoma: immunotherapy landscape beyond PD-1 and CTLA-4 inhibitionFiras Y Kreidieh, Hussein A Tawbi
Clinical Advances in Hematology & Oncology : H&O|October 7, 2022
Current and emerging options for patients with melanoma brain metastasesFiras Y Kreidieh, Hussein A Tawbi
Seminars in Oncology|December 18, 2007
Management of metastatic melanomaHussein A Tawbi, John M Kirkwood
Cancer Discovery|May 5, 2021
Bispecific Antibodies to PD-1 and CTLA4: Doubling Down on T Cells to Decouple Efficacy from ToxicityElizabeth M Burton, Hussein A Tawbi
Cancer Discovery|August 5, 2018
Engineered T Cells in Synovial Sarcoma: Persistence Pays Off!Emily Z Keung, Hussein A Tawbi
Clinical Advances in Hematology & Oncology : H&O|May 28, 2010
Chemotherapy resistance abrogation in metastatic melanomaHussein A Tawbi, Shama C Buch
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Cancer Journal (Sudbury, Mass.)|March 25, 2024
Local and Systemic Management Options for Melanoma Brain MetastasesAfsaneh Amouzegar, Hussein A Tawbi
Neuro-Oncology Advances|December 3, 2021
Emergent immunotherapy approaches for brain metastasesJianbo Wang, Hussein A Tawbi
Expert Opinion on Investigational Drugs|April 17, 2012
A potential role for nilotinib in KIT-mutated melanomaAn Tran, Hussein A Tawbi
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2021
Nonsurgical Management of Melanoma Brain Metastasis: Current Therapeutics, Challenges, and Strategies for ProgressShalini Makawita, Hussein A Tawbi
Therapeutic Advances in Medical Oncology|July 24, 2023
The introduction of LAG-3 checkpoint blockade in melanoma: immunotherapy landscape beyond PD-1 and CTLA-4 inhibitionFiras Y Kreidieh, Hussein A Tawbi
Clinical Advances in Hematology & Oncology : H&O|October 7, 2022
Current and emerging options for patients with melanoma brain metastasesFiras Y Kreidieh, Hussein A Tawbi
Seminars in Oncology|December 18, 2007
Management of metastatic melanomaHussein A Tawbi, John M Kirkwood
Cancer Discovery|May 5, 2021
Bispecific Antibodies to PD-1 and CTLA4: Doubling Down on T Cells to Decouple Efficacy from ToxicityElizabeth M Burton, Hussein A Tawbi
Cancer Discovery|August 5, 2018
Engineered T Cells in Synovial Sarcoma: Persistence Pays Off!Emily Z Keung, Hussein A Tawbi
Clinical Advances in Hematology & Oncology : H&O|May 28, 2010
Chemotherapy resistance abrogation in metastatic melanomaHussein A Tawbi, Shama C Buch
Pageof 11